Correlation Between NYSE Composite and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Elevation Oncology, you can compare the effects of market volatilities on NYSE Composite and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Elevation Oncology.
Diversification Opportunities for NYSE Composite and Elevation Oncology
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between NYSE and Elevation is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of NYSE Composite i.e., NYSE Composite and Elevation Oncology go up and down completely randomly.
Pair Corralation between NYSE Composite and Elevation Oncology
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.1 times more return on investment than Elevation Oncology. However, NYSE Composite is 10.18 times less risky than Elevation Oncology. It trades about 0.02 of its potential returns per unit of risk. Elevation Oncology is currently generating about -0.11 per unit of risk. If you would invest 1,907,793 in NYSE Composite on December 30, 2024 and sell it today you would earn a total of 19,237 from holding NYSE Composite or generate 1.01% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Elevation Oncology
Performance |
Timeline |
NYSE Composite and Elevation Oncology Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Elevation Oncology
Pair trading matchups for Elevation Oncology
Pair Trading with NYSE Composite and Elevation Oncology
The main advantage of trading using opposite NYSE Composite and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.NYSE Composite vs. Corby Spirit and | NYSE Composite vs. Church Dwight | NYSE Composite vs. Nascent Wine | NYSE Composite vs. Crocs Inc |
Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |